Found 15 matching trials
Stratified Pharmacological Approaches for Regulating Circuit-Level Effects PHASE2 This research study aims to understand how people with depression respond t...
Show More Location
Stanford University
Learn More & Join Trial
Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria PHASE2 A randomized, double-blind, placebo-controlled, flexible dose study to eval...
Show More Location
248.644.0026 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients PHASE3 The objectives of this trial conducted in early Parkinson's Disease (PD) pa...
Show More Location
248.524.01018 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A Study in Patients With Major Depressive Disorder PHASE2 This is a Phase 2a, placebo-controlled, single-blind study in up to 24 pati...
Show More Location
Collaborative Neuroscience Network
Learn More & Join Trial
Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers PHASE1 The objectives of the studies are:
* To demonstrate similar total exposure...
Show More Location
Multiple Locations
Learn More & Join Trial
Pivotal Study in Advanced Parkinsons Disease Patients PHASE3 The general aim of this trial is to determine the efficacy (as measured by ...
Show More Location
248.525.43005 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa PHASE4 The main objective of the study is to explore firstly, then further evaluat...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male Volunteers PHASE1 The objectives of this study were to investigate relative BA at steady stat...
Show More Location
Multiple Locations
Learn More & Join Trial
Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers PHASE1 The objective of the study is to assess that pramipexole does not prolong t...
Show More Location
Multiple Locations
Learn More & Join Trial
A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period PHASE2 The objective of this trial is to investigate the safety, tolerability, tro...
Show More Location
248.610.019 Boehringer Ingelheim Investigational Site
Learn More & Join Trial